A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687

Molecular Immunology

Volumn 45, Issue 5, 2008, Pages 1374-1384

  Lu, Hsin Lin ^a   Yang, Chih Yung ^a   Chen, Hui Chun ^a   Hung, Chia Sui ^a   Chiang, Yu Chi ^a   Ting, Ling Pai ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

IL 1 receptor; IL 1 receptor accessory protein; IL 1 signal transduction; Interleukin 1; MyD88; Tollip

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MEMBRANE INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN 687; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CELL LINE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN; NF-KAPPA B; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 37449007092     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.09.002     Document Type: Article

References (29)

1. Burns K., Clatworthy J., Martin L., Martinon F., Plumpton C., Maschera B., Lewis A., Ray K., Tschopp J., and Volpe F. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2 (2000) 346-351
2. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., Di Marco F., French L., and Tschopp J. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273 (1998) 12203-12209
3. Casadio R., Frigimelica E., Bossu P., Neumann D., Martin M.U., Tagliabue A., and Boraschi D. Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett. 499 (2001) 65-68
4. Cullinan E.B., Kwee L., Nunes P., Shuster D.J., Ju G., McIntyre K.W., Chizzonite R.A., and Labow M.A. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J. Immunol. 161 (1998) 5614-5620
5. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
6. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20 (2002) S1-S13
7. Dunne A., and O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2003 (2003) re3
8. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T., McMurray D., Smith D.E., Sims J.E., Bird T.A., and O'Neill L.A. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413 (2001) 78-83
9. Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., and Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270 (1995) 13757-13765
10. Huang J., Gao X., Li S., and Cao Z. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12829-12832
11. Huang Y.S., Misior A., and Li L.W. Novel role and regulation of the interleukin-1 receptor associated kinase (IRAK) family proteins. Cell Mol. Immunol. 2 (2005) 36-39
12. Janssens S., and Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11 (2003) 293-302
13. Janssens S., Burns K., Tschopp J., and Beyaert R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr. Biol. 12 (2002) 467-471
14. Jensen L.E., Muzio M., Mantovani A., and Whitehead A.S. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J. Immunol. 164 (2000) 5277-5286
15. Jensen L.E., and Whitehead A.S. IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability. J. Biol. Chem. 276 (2001) 29037-29044
16. Jensen L.E., and Whitehead A.S. Expression of alternatively spliced interleukin-1 receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis. Cell Signal. 15 (2003) 793-802
17. Jensen L.E., and Whitehead A.S. The 3′ untranslated region of the membrane-bound IL-1R accessory protein mRNA confers tissue-specific destabilization. J. Immunol. 173 (2004) 6248-6258
18. Li X., and Qin J. Modulation of Toll-interleukin 1 receptor mediated signaling. J. Mol. Med. 83 (2005) 258-266
19. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., and Janeway Jr. C.A. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2 (1998) 253-258
20. Neumann D., Kollewe C., Martin M.U., and Boraschi D. The membrane form of the type II IL-1 receptor accounts for inhibitory function. J. Immunol. 165 (2000) 3350-3357
21. Radons J., Dove S., Neumann D., Altmann R., Botzki A., Martin M.U., and Falk W. The interleukin 1 (IL-1) receptor accessory protein Toll/IL-1 receptor domain: analysis of putative interaction sites in vitro mutagenesis and molecular modeling. J. Biol. Chem. 278 (2003) 49145-49153
22. Rao N., Nguyen S., Ngo K., and Fung-Leung W.P. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol. Cell. Biol. 25 (2005) 6521-6532
23. Smith D.E., Hanna R., Della F., Moore H., Chen H., Farese A.M., MacVittie T.J., Virca G.D., and Sims J.E. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity 18 (2003) 87-96
24. Subramaniam S., Stansberg C., and Cunningham C. The interleukin 1 receptor family. Dev. Comp. Immunol. 28 (2004) 415-428
25. Towne J.E., Garka K.E., Renshaw B.R., Virca G.D., and Sims J.E. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J. Biol. Chem. 279 (2004) 13677-13688
26. Vigers G.P., Anderson L.J., Caffes P., and Brandhuber B.J. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature 386 (1997) 190-194
27. Wesche H., Henzel W.J., Shillinglaw W., Li S., and Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7 (1997) 837-847
28. Wesche H., Korherr C., Kracht M., Falk W., Resch K., and Martin M.U. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272 (1997) 7727-7731
29. Yang C.Y., Kuo T.H., and Ting L.P. Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response. J. Biol. Chem. 281 (2006) 34525-34536